One Huge Drug Company Gave Up - But We Won't
There's no denying that Alzheimer's research is expensive, tedious, and sometimes leads to dead ends. Most medical research does. This year, that expense led a major pharmaceutical company to announce that they're giving up on this disease - on the 5 million Americans who suffer from it - because their shareholders think it's unprofitable.
But we cannot, we will not give up like they did. Our loved ones' lives are at stake.Fight Alzheimer's